title: Do COX-2 inhibitors really prevent hypertension and proteinuria? Another brick in the wall for the COX-2 inhibition and cardiovascular disease controversy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Cosentino
authors.forename: Pietro
authors.initials: P
authors.lastname: Francia
authors.forename: Massimo
authors.initials: M
authors.lastname: Volpe
mesh_terms: D000818:Animals; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D006801:Humans; D006973:Hypertension / Q000517:prevention & control*; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D008565:Membrane Proteins; D019331:NG-Nitroarginine Methyl Ester / Q000633:toxicity; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000172:deficiency; D011451:Prostaglandin-Endoperoxide Synthases; D011507:Proteinuria / Q000517:prevention & control*; D051381:Rats
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D009569:Nitric Oxide; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D019331:NG-Nitroarginine Methyl Ester